Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
41.95 CHF | +0.60% | +3.45% | +18.84% |
Apr. 09 | Basilea Pharmaceutica Receives Grant for Antibiotics Program | MT |
Apr. 04 | Stocks Close in Green as Swiss Inflation Unexpectedly Slows | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.84% | 553M | |
-1.82% | 41.35B | |
+44.25% | 40.38B | |
+2.56% | 39.05B | |
-12.11% | 26.67B | |
+3.09% | 24.07B | |
-24.16% | 18.36B | |
+22.12% | 11.6B | |
-3.74% | 11.68B | |
+7.75% | 11.15B |
- Stock Market
- Equities
- BSLN Stock
- News Basilea Pharmaceutica AG
- Basilea To Sell Preclinical CLK Kinase Inhibitors To Twentyeight-Seven Therapeutics